文献速递糖尿病

在死亡中识别正确的糖尿病诊断:解锁理解1型糖尿病发病机制的关键

Identifying the Right Diagnosis of Diabetes in Death: Unlocking A Key to Understanding Type 1 Diabetes Pathogenesis.
PubMed 文献 · Diabetes Care · 2026-07-22

糖尿病准确分型仍具挑战,成人因表型重叠易误分类。本文基于nPOD等器官捐献项目的人胰腺组织研究,提出结合临床变量、组织病理学(胰岛素阴性胰岛、胰岛炎)和遗传学(1型糖尿病遗传风险评分)的分类路径,以更全面诊断1型糖尿病并推动精准分型。

要点

  • 糖尿病分类困难源于临床特征重叠与异质性,成人尤其易误分类。
  • 尸检胰腺组织研究支持将组织病理学和遗传学纳入分类路径。
  • 整合器官捐献研究与完整临床数据可提高诊断准确性并推进个体化诊疗。

核心结论

  • 基于频谱的糖尿病病理生理观优于 rigid 分类定义,需改进生物标志物与机制理解。
  • 结合组织病理学与遗传学特征可支持更全面的1型糖尿病诊断,可能涵盖非典型形式。

研究设计与样本

  • 综述/观点性文章,基于过去二十年通过nPOD及相关项目获取的人胰腺组织研究。

主要发现

  • 成人糖尿病因肥胖合并自身免疫等非典型表现导致误分类常见。
  • 误分类可导致治疗决策欠佳、血糖达标延迟及长期并发症风险增加。
  • 尸检糖尿病分类挑战促成纳入临床变量、组织病理学和遗传学的分类路径。

关键数值与推荐

  • 组织病理学出现胰岛素阴性胰岛和胰岛炎病变支持1型糖尿病诊断。
  • 临床特征如C肽丢失和1型糖尿病遗传风险评分升高支持更全面诊断。

临床怎么用

  • 在糖尿病分型中考虑整合临床、组织病理学和遗传学信息以提高准确性。
  • 对非典型表现(如肥胖合并自身免疫)保持警惕,避免误分类。

局限性

  • 组织见解基于终末住院时有限的临床数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Accurate classification of diabetes into type 1, type 2, or monogenic forms remains a major challenge. This difficulty arises from overlapping clinical features and substantial heterogeneity within these conditions, particularly in adults, due to nonconforming presentations such as obesity coexisting with autoimmunity. Consequently, misclassification is common and can contribute to suboptimal therapeutic decisions, delayed achievement of glycemic targets, and increased risk of long-term complications. Growing evidence supports a spectrum-based view of diabetes pathophysiology rather than rigid categorical definitions, highlighting the need for improved biomarkers and a deeper mechanistic understanding of disease processes. To address this knowledge gap, over the past two decades we have conducted studies of human pancreata obtained through the Network for Pancreatic Organ donors with Diabetes (nPOD) and related programs, enabling in situ investigation of disease pathogenesis. Insights derived from such tissues and their biological relevance are based on limited clinical data at the time of terminal hospitalization. Challenges with postmortem diabetes classification have led to the creation of classification pathways that include not only clinical variables but also histopathology and genetics. For example, including the presence of insulin-negative islets and insulitic lesions on histopathology and clinical features such as C-peptide loss and increased type 1 diabetes genetic risk score, over clinical history alone, supports a more holistic diagnosis of type 1 diabetes, which may include atypical forms of diabetes. Continued integration of organ donor-based research with comprehensive clinical data is essential to refine classification systems, improve diagnostic accuracy, and advance personalized approaches to diabetes care.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Jacobsen LM, Campbell-Thompson M, Wasserfall C, et al. Identifying the Right Diagnosis of Diabetes in Death: Unlocking A Key to Understanding Type 1 Diabetes Pathogenesis. Diabetes Care. 2026. PMID: 42485182. doi:10.2337/dci26-0020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。